Repligen Corp. (RGEN)
125.00
-0.76
(-0.60%)
USD |
NASDAQ |
May 07, 09:43
Repligen Free Cash Flow : 104.46M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Masimo Corp. | 206.10M |
| Orthofix Medical, Inc. | -4.463M |
| InfuSystem Holdings, Inc. | 23.85M |
| Tandem Diabetes Care, Inc. | -29.67M |
| 908 Devices, Inc. | -8.421M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 28.30M |
| Cash from Investing (Quarterly) | -3.988M |
| Cash from Financing (Quarterly) | -5.543M |
| Free Cash Flow Per Share (Quarterly) | 0.412 |
| Free Cash Flow to Equity (Quarterly) | 25.68M |
| Free Cash Flow to Firm (Quarterly) | 51.55M |
| Free Cash Flow Yield | 1.48% |